New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 8, 2014
10:41 EDTAET, CVS, WMTAetna adds Wal-Mart to preferred pharmacy network of Aetna CVS plan
Aetna (AET) announced that Walmart (WMT) and Samís Club pharmacies will be added to the preferred pharmacy network of the Aetna CVS/pharmacy Prescription Drug Plan as of January 1. The Aetna CVS/pharmacy Prescription Drug Plan is available in 43 states and the District of Columbia.
News For AET;WMT;CVS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 >>
October 2, 2015
08:21 EDTCVS, WMTAmazon to be number two player in U.S. consumables by 2018, says Cowen
John Blackledge and the research team at Cowen project that (AMZN) will grow to be the number two player in the $425B market for U.S. consumables - which they define as personal care, household, pet and baby products - by 2018. The firm expects Amazon to use its multi-platform approach, centered around Prime, to help the e-commerce giant gain share in consumables at the expense of Wal-Mart (WMT), Target (TGT), Walgreens (WBA) and CVS Health (CVS). Cowen has Outperform ratings on Amazon and Target and a Market Perform rating on shares of Wal-Mart.
06:51 EDTWMTWal-Mart Chile eyes shopping center chain sale, Reuters says
Wal-Mart Chile is eyeing a sale of its chain of shopping centers in an effort to focus on its larger supermarket operations in Chile, Reuters reports. The plan would involve the sale of 10 "Espacio Urbano" centers throughout the country, totaling roughly 250,000 square meets, the report says. Reference Link
October 1, 2015
10:50 EDTCVSLeerink healthcare services analyst holds analyst/industry conference call
Analyst Larsen, along with Dan Steiber of D2 Pharma Consulting and James Kenney, Jr., of Harvard Pilgrim Health Care, discuss Hillary Care's potential impact to the Prescription Drug Supply Chain, the impact of the Medicaid rebate program and the uptake of bio-similars and generic launches in 2015 on an Analyst/Industry conference call to be held on October 2 at 12 pm.
10:37 EDTWMTBofA/Merrill's Top 10 US Ideas for Q4 2015
Subscribe for More Information
08:10 EDTWMTAmerican Express cards now accepted at Sam's Club
Subscribe for More Information
06:16 EDTWMTWal-Mart to lay off hundreds of employees at Arkansas headquarters, Reuters says
Wal-Mart plans to cut hundreds of jobs at its headquarters in Arkansas in an effort to pare costs, Reuters reports, citing people familiar with the matter. Fewer than 500 employees are expected to have their employment terminated and an announcement could come as early as Friday, the report says. Reference Link
September 30, 2015
10:47 EDTCVSLeerink analyst/industry conference call date/time changed from October 8 10 am
Healthcare Distribution & Technology Larsen, along with Diplomat Pharmacy Chairman & CEO Hagerman and CFO & Secretary/Treasurer Whelan, provide industry insights including the potential impact of Hillary Care, the influence CMS may have on overall drug pricing and recent stock volatility on an Analyst/Industry conference call now being held at a new date and time of September 30 at 5 pm.
09:05 EDTCVSCVS Health announces partnership with MassChallenge and Rock Health
CVS Health announced that it was partnering with top startup accelerator MassChallenge and digital health venture fund Rock Health to drive faster innovation and expand areas of focus for connected health solutions.
September 29, 2015
09:39 EDTAETHouse Judiciary Committee to hold a hearing
Subscribe for More Information
07:11 EDTWMTWal-Mart expands pick-up service to new markets, Fortune says
Subscribe for More Information
September 28, 2015
06:42 EDTWMTPerfume makers look to Wal-Mart, Target, WSJ reports
Subscribe for More Information
September 25, 2015
06:39 EDTAETAPA: Big insurance firm mergers could harm mental healthcare, Reuters says
Subscribe for More Information
September 23, 2015
18:14 EDTWMTWal-Mart seeks 2%-6% cuts on China-made goods from suppliers, Reuters says
Subscribe for More Information
18:06 EDTWMTWal-Mart seeks 2%-6% cuts on China-made goods from suppliers, Reuters says
08:11 EDTAETLeerink sees less political risk for Managed Care mergers after hearings
Subscribe for More Information
September 22, 2015
20:02 EDTAETClinton vows $250 cap on monthly drug costs in blast against biotechs, insurers
Democratic presidential candidate Hillary Clinton railed against biotech companies as well as health insurers at a community health care forum in Iowa on Tuesday. Clinton began her speech by praising the Affordable Care Act, but quickly noted that she wants to strengthen it due to what she called the rising cost of prescription drugs. She explained, "Our pharmaceutical and biotechnology industries deserve credit... [But] too often, these drugs cost a fortune. Now, sometimes there is a good reason for that. Scientific breakthroughs are often the result of major investment... so it may makes sense, for a short period of time, to have to charge a lot of money for a drug. But when a drug has no competition, when there aren't any other treatments that can do what it does, pharmaceutical companies can charge astronomical fees far beyond anything that it would take to recoup their investment, and far beyond what they charge consumers anywhere else in the world outside of America." Referencing the recent criticism against Turing Pharmaceuticals, Clinton went on to say that "pharmaceutical companies that acquire an existing affordable drug that people rely on, and then turn around and charge a fortune for it, [are just betting] on the fact that desperate people will find some way to pay for it." Preemptively responding to questions of whether greater regulation will dampen investment, Clinton commented that "some people worry that my proposals will threaten innovation, but I have designed a plan that will do exactly the opposite... Under my plan, drug companies that want to keep getting federal support will have to redirect more of their profits into meaningful investments in research and development." Clinton also criticized incremental drug improvements, saying that "too often, so-called new drugs are really old drugs that have just been tweaked a little bit, but then they're marketed as breakthrough drugs and they're sold for high prices." The Democratic candidate went on to condemn advertising in the drug industry, remarking that "I also want to tackle direct to consumer advertising... Other countries ban these ads because they are so often misleading. But at the very least, we shouldn't be encouraging them with corporate write-offs... Under my plan, we will instead use that taxpayer money to fund innovation... I would also like to make sure any ads the drug industry does run are approved by the FDA." Moving more broadly onto Medicaid and health insurers, Clinton stated, "I believe Medicare should be able to negotiate for lower prices for its members... I will require drug companies to provide higher rebates for prescription drugs to low income Medicare patients, just like they have to do for Medicaid patients... I think the insurance companies need to be put on notice." Providing more concrete details of her plan, Clinton concluded, "I will cap out of pocket drug costs for working families. You won't have to pay more than $250 a month for covered medications... Particularly for people who have a chronic illness. Also under my plan, you will be able to import cheaper drugs from other countries legally. If the medicine you need costs less in Canada, you should be able to buy it from Canada or any other country that meets our safety standards... I will also make sure we have more generics on the market [by boosting funding for] the FDA's office of generic drugs."
14:52 EDTAETAetna plans to raise Humana wages after merger, Bloomberg says
Aetna (AET) CEO Mark Bertolini plans to raise wages to $16 per hour for about 10,000 low-wage Humana (HUM) employees if the prospective merger of the two companies goes through, reports Bloomberg, citing written testimony at a U.S. Senate subcommittee hearing. "Our hope is these initiatives will help reduce employee turnover," explained Bertolini. Reference Link
10:45 EDTWMT, CVSReimbursement pressure on drug stores should moderate, says Cleveland Research
Cleveland Research analysts Rob Eich and Rob Stuyck said the firm's work indicates that stepdown reimbursement rates will be more manageable for drug store operators and that generic inflation will be less of a headwind for the group in FY16. However, Direct and Indirect Remuneration clauses will still be a source of margin pressure, the firm said, noting that several payers will be introducing a DIR next year. Cleveland Research has Neutral ratings on CVS (CVS), Walgreens (WBA), Rite Aid (RAD) and Wal-Mart (WMT).
08:37 EDTAETAetna, Anthem CEOs set to testify to Senate committee, WSJ reports
Subscribe for More Information
07:47 EDTAETSenate Judiciary Committee to hold a hearing
Subscribe for More Information
1 | 2 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use